©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessRett-like syndrome, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Rett-like syndrome comprising 1 guideline-curated core gene, 9 core candidate genes and altogether 56 curated genes according to the clinical signs

ID
RP0700
Number of genes
56 Accredited laboratory test
Examined sequence length
24,3 kb (Core-/Core-canditate-Genes)
153,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
ARX1689NM_139058.3XL
CDKL53093NM_003159.3XL
FOXG11470NM_005249.5AD
MECP21461NM_004992.4XL
MEF2C1422NM_002397.5AD
SCN2A6018NM_021007.3AD
STXBP11812NM_003165.6AD, AR
UBE3A2559NM_130838.4AD
WDR451086NM_007075.4XL
ZEB23645NM_014795.4AD
CNPY3837NM_006586.5AR
CUX24461NM_015267.4AD
DENND5A3864NM_015213.4AR
DNM12595NM_004408.4AD
DOCK76390NM_001271999.2AR
EEF1A21392NM_001958.5AD
FRRS1L1035NM_014334.4AR
GABBR22826NM_005458.8AD
GABRA11371NM_000806.5AD
GABRA21356NM_001114175.3AD
GABRB31422NM_000814.6AD
GABRG21404NM_000816.3AD
GNAO11065NM_020988.3AD
GRIN2B4455NM_000834.5AD
HCN12673NM_021072.4AD
HNRNPU2478NM_031844.3AD
ITPA585NM_033453.4AR
KCNA21500NM_004974.4AD
KCNB12577NM_004975.4AD
KCNQ22619NM_172107.4AD
KCNT13708NM_020822.3AD
MDH21017NM_005918.4AR
NTRK22517NM_006180.6AD
PARS21428NM_152268.4AR
PCDH193447NM_001184880.2XL
PHACTR11743NM_001242648.4AD
PIGQ1746NM_004204.5AR
PLCB13651NM_015192.4AR
SCN1A6030NM_001165963.4AD
SCN1B657NM_001037.5AD, AR
SCN3A6003NM_006922.4AD
SCN8A5943NM_014191.4AD
SLC12A53351NM_020708.5AD, AR
SLC13A51707NM_177550.5AR
SLC1A21725NM_004171.4AD
SLC25A122037NM_003705.5AR
SLC25A22972NM_024698.6AR, AD
SPTAN17434NM_001130438.3AD
ST3GAL31128NM_006279.5AR
SYNGAP14032NM_006772.3AD
SYNJ14839NM_003895.3AR
SZT210128NM_015284.4AR
TBC1D241680NM_001199107.2AR
TRAK12862NM_001042646.3AR
WASF11688NM_003931.3AD
WWOX1245NM_016373.4AR

Informations about the disease

Clinical Comment

Rett-like or Rett-variant syndrome has a broader clinical spectrum than classic Rett syndrome in females. This ranges from mild learning difficulties to severe neonatal encephalopathy or Parkinsonism or severe syndromic psychomotor retardation. The symptoms therefore appear early, and the different inheritance patterns depend on the gene (or genes) involved. Even by means of extensive panel examinations with several dozen genes, depending on the clinical clarification, no simple genetic cause can be found in some patients.

Reference: https://www.ncbi.nlm.nih.gov/books/NBK1497/

 

Synonyms
  • Sympt.: Autism, dementia, ataxia, loss of purposeful hand use
  • Sympt.: Developmental decline, speech loss, stereotypic movements hands, microcephaly, seizures, MR
  • Alias: Rett syndrome, atypical
  • Allelic: Autism susceptibility, XL 3 (MECP2)
  • Allelic: Brugada syndrome 5 (SCN1B)
  • Allelic: Chromosome 5q14.3 deletion syndrome (MEF2C)
  • Allelic: DOORS syndrome (TBC1D24)
  • Allelic: Deafness , Ar 86 (TBC1D24)
  • Allelic: Deafness, AD 65 (TBC1D24)
  • Allelic: Encephalopathy, neonatal severe (MECP2)
  • Allelic: Epilepsy, familial focal, with variable foci 4 (SCN3A)
  • Allelic: Epilepsy, generalized, with febrile seizures plus, type 1 (SCN1B)
  • Allelic: Epilepsy, generalized, with febrile seizures plus, type 2 (SCN1A)
  • Allelic: Epilepsy, generalized, with febrile seizures plus, type 3 (GABRG2)
  • Allelic: Epilepsy, nocturnal frontal lobe, 5 (KCNT1)
  • Allelic: Epilepsy, rolandic, with proxysmal exercise-induce dystonia + writer's cramp (TBC1D24)
  • Allelic: Episodic ataxia, type 9 (SCN2A)
  • Allelic: Esophageal squamous cell carcinoma, somatic (WWOX)
  • Allelic: Febrile seizures, familial, 3A (SCN1A)
  • Allelic: Febrile seizures, familial, 8 (GABRG2)
  • Allelic: Generalized epilepsy with febrile seizures plus, type 10 (HCN1)
  • Allelic: Hydranencephaly with abnormal genitalia (ARX)
  • Allelic: Lissencephaly, XL 2 (ARX)
  • Allelic: Mental retardation, AD 38 (EEF1A2)
  • Allelic: Mental retardation, AD 6 (GRIN2B)
  • Allelic: Mental retardation, AR 12 (ST3GAL3)
  • Allelic: Mental retardation, XL 29 + others (ARX)
  • Allelic: Mental retardation, XL syndromic, Lubs type (MECP2)
  • Allelic: Mental retardation, XL, syndromic 13 (MECP2)
  • Allelic: Migraine, familial hemiplegic, 3 (SCN1A)
  • Allelic: Myoclonic epilepsy, infantile, familial (TBC1D24)
  • Allelic: Myokymia (KCNQ2)
  • Allelic: Obesity, hyperphagia + developmental delay (NTRK2)
  • Allelic: Parkinson disease 20, early-onset (SYNJ1)
  • Allelic: Seizures, benign familial infantile, 3 (SCN2A)
  • Allelic: Seizures, benign familial infantile, 5 (SCN8A)
  • Allelic: Seizures, benign neonatal, 1 (KCNQ2)
  • Allelic: Spinocerebellar ataxia, AR 12 (WWOX)
  • Angelman syndrome (UBE3A)
  • Chromosome 5q14.3 deletion syndrome (MEF2C)
  • Epileptic encephalopathy, early infantile, 1 (ARX)
  • Epileptic encephalopathy, early infantile, 11 (SCN2A)
  • Epileptic encephalopathy, early infantile, 12 (PLCB1)
  • Epileptic encephalopathy, early infantile, 13 (SCN8A)
  • Epileptic encephalopathy, early infantile, 14 (KCNT1)
  • Epileptic encephalopathy, early infantile, 15 (ST3GAL3)
  • Epileptic encephalopathy, early infantile, 16 (TBC1D24)
  • Epileptic encephalopathy, early infantile, 17 (GNAO1)
  • Epileptic encephalopathy, early infantile, 18 (SZT2)
  • Epileptic encephalopathy, early infantile, 19 (GABRA1)
  • Epileptic encephalopathy, early infantile, 2 (CDKL5)
  • Epileptic encephalopathy, early infantile, 23 (DOCK7)
  • Epileptic encephalopathy, early infantile, 24 (HCN1)
  • Epileptic encephalopathy, early infantile, 25 (SLC13A5)
  • Epileptic encephalopathy, early infantile, 26 (KCNB1)
  • Epileptic encephalopathy, early infantile, 27 (GRIN2B)
  • Epileptic encephalopathy, early infantile, 28 (WWOX)
  • Epileptic encephalopathy, early infantile, 3 (SLC25A22)
  • Epileptic encephalopathy, early infantile, 31 (DNM1)
  • Epileptic encephalopathy, early infantile, 32 (KCNA2)
  • Epileptic encephalopathy, early infantile, 33 (EEF1A2)
  • Epileptic encephalopathy, early infantile, 34 (SLC12A5)
  • Epileptic encephalopathy, early infantile, 35 (ITPA)
  • Epileptic encephalopathy, early infantile, 37 (FRRS1L)
  • Epileptic encephalopathy, early infantile, 39 /SLC25A12)
  • Epileptic encephalopathy, early infantile, 4 (STXBP1)
  • Epileptic encephalopathy, early infantile, 41 (SLC1A2)
  • Epileptic encephalopathy, early infantile, 43 (GABRB3)
  • Epileptic encephalopathy, early infantile, 49 (DENND5A)
  • Epileptic encephalopathy, early infantile, 5 (SPTAN1)
  • Epileptic encephalopathy, early infantile, 51 (MDH2)
  • Epileptic encephalopathy, early infantile, 52 (SCN1B)
  • Epileptic encephalopathy, early infantile, 53 (SYNJ1)
  • Epileptic encephalopathy, early infantile, 54 (HNRNPU)
  • Epileptic encephalopathy, early infantile, 58 (NTRK2)
  • Epileptic encephalopathy, early infantile, 59 (GABBR2)
  • Epileptic encephalopathy, early infantile, 6 [Dravet syndrome] (SCN1A)
  • Epileptic encephalopathy, early infantile, 60 (CNPY3)
  • Epileptic encephalopathy, early infantile, 62 (SCN3A)
  • Epileptic encephalopathy, early infantile, 67 (CUX2)
  • Epileptic encephalopathy, early infantile, 68 (TRAK1)
  • Epileptic encephalopathy, early infantile, 7 (KCNQ2)
  • Epileptic encephalopathy, early infantile, 70 (PHACTR1)
  • Epileptic encephalopathy, early infantile, 74 (GABRG2)
  • Epileptic encephalopathy, early infantile, 75 (PARS2)
  • Epileptic encephalopathy, early infantile, 77 (PIGQ)
  • Epileptic encephalopathy, early infantile, 78 (GABRA2)
  • Epileptic encephalopathy, early infantile, 9 (PCDH19)
  • Mental retardation, AD 5 (SYNGAP1)
  • Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations (MEF2C)
  • Mowat-Wilson syndrome (ZEB2)
  • Neurodegeneration with brain iron accumulation 5 (WDR45)
  • Neurodevelopmental disorder with involuntary movements (GNAO1)
  • Neurodevelopmental disorder with poor language + loss of hand skills (GABBR2)
  • Partington syndrome (ARX)
  • Proud syndrome (ARX)
  • Rett syndrome (MECP2)
  • Rett syndrome, atypical (MECP2)
  • Rett syndrome, congenital variant (FOXG1)
  • Rett syndrome, preserved speech variant (MECP2)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.